Green Thumb Industries (GTBIF) Interest Expenses (2019 - 2026)
Green Thumb Industries (GTBIF) posted Interest Expenses of $207.6 million for Q1 2026, up 3851.28% on a QoQ basis from $5.3 million in Q4 2025, and down 59.74% year-over-year from $515.6 million in Q1 2025.
Green Thumb Industries (GTBIF) Interest Expenses (2019 - 2026) Analysis & Trends
Green Thumb Industries' Interest Expenses history runs 8 years deep, the most recent figure standing at $207.6 million for Q1 2026.
- Quarterly Interest Expenses fell 59.74% year-over-year to $207.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $207.6 million (down 59.74% YoY) and the FY2025 annual result came in at $221.5 million, up 813.0% from the prior year.
- Interest Expenses was $207.6 million for Q1 2026 at Green Thumb Industries, up from $5.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $558.1 million in Q3 2022 and bottomed at $4.9 million in Q4 2022.
- A 5-year average of $341.1 million and a median of $439.3 million in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses jumped 90.57% — and 2026, when it sank 59.74%.
- Green Thumb Industries' Interest Expenses stood at $4.9 million in 2022, then rose by 10.2% to $5.3 million in 2023, then advanced by 2.37% to $5.5 million in 2024, then dropped by 4.04% to $5.3 million in 2025, then jumped by 3851.28% to $207.6 million in 2026.
- Business Quant data shows GTBIF's Interest Expenses at $207.6 million in Q1 2026, $5.3 million in Q4 2025, and $497.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 207.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 207.60 Mn |
| Mar 31, 2026 | 207.60 Mn |
| Dec 31, 2025 | 5.25 Mn |
| Dec 31, 2025 | 5.25 Mn |
| Sep 30, 2025 | 497.83 Mn |
| Sep 30, 2025 | 497.83 Mn |
| Jun 30, 2025 | 234.81 Mn |
| Jun 30, 2025 | 234.81 Mn |
| Mar 31, 2025 | 515.59 Mn |
| Mar 31, 2025 | 515.59 Mn |
| Dec 31, 2024 | 5.48 Mn |
| Dec 31, 2024 | 5.48 Mn |
| Sep 30, 2024 | 530.58 Mn |
| Sep 30, 2024 | 530.58 Mn |
| Jun 30, 2024 | 536.82 Mn |
| Jun 30, 2024 | 536.82 Mn |
| Mar 31, 2024 | 531.17 Mn |
| Mar 31, 2024 | 531.17 Mn |
| Dec 31, 2023 | 5.35 Mn |
| Dec 31, 2023 | 5.35 Mn |